Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

The DermLep Study I: Results of Prospective Nation-Wide Survey of the Number & Profile of Leprosy Patients seen by Dermatologists in India.

Rao NP, Rathod S, Suneetha S, et al. Indian dermatology online journal. 2020; 11 (5) : 701-711.
Download PDF
Publication

Epidemiological situation of leprosy in a province in China: a long time to diagnosis and a high rate of deformity.

Zhang Q, Li G, Li C, et al. BMC public health. 2020; 20 (1) : 1790.
Download PDF
Publication

Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.

De Barros B, Lambert S, Shah M, et al. BMJ open. 2020; 10 (11) : e037700.
Download PDF
Publication

Can the municipal social deprivation index influence the time trend of the leprosy detection rate?

Souza CDFD, Santos V, Nery J, et al. Revista da Sociedade Brasileira de Medicina Tropical. 2020;
Download PDF
Publication

Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020

WHO/Department of control of neglected tropical diseases . World Health Organization. 2020;
Download PDF
Publication

Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis

World Health Organization . World Health Organization. 2020;
Download PDF
Publication

A cross-sectional study to evaluate depression and quality of life among patients with lymphoedema due to podoconiosis, lymphatic filariasis and leprosy.

Ali O, Deribe K, Semrau M, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2020;
Publication

Analysis Of Disability And Stigma On Self-Concept On Leprosy Patients

Mahanani S, Idris DNT. Institut Ilmu Kesehatan STRADA Indonesia (STRADA Indonesia Health Sciences Institute). STRADA Jurnal Ilmiah Kesehatan. 2020; 9 (2) : 926-935.
Download PDF
Publication

Evaluation Of Leprosy Management Program Implementation In Karang Penang Health Center, Sampang District, Madura

Nugraheni R, Wardani MK. Institut Ilmu Kesehatan STRADA Indonesia (STRADA Indonesia Health Sciences Institute). STRADA Jurnal Ilmiah Kesehatan. 2020; 9 (2) : 879-885.
Download PDF
Publication

Prevalência de Hanseníase na Baixada Maranhense do Brasil

Batista JE, Campos VC, Santos GRBD, et al. Research, Society and Development. Research, Society and Development. 2020; 9 (11) : e1699117989.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 328
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD